AMLODIPINE-OLMESARTAN 5-20 MG

AMLODIPINE and OLMESARTAN medoxomil
$0.2347per EA

Strength

5; 20 mg/1; mg/1

NDC

33342019007

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206884

On Market Since

10/27/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price History

1W

0.0%

1M

-2.2%

3M

-4.9%

6M

-7.1%

1Y

-25.4%

3Y

-39.5%

5Y

-31.5%

All

-74.7%